Boron Prevents Oral Acrylamide Damage in Bone Marrow and Hematologic Parameters of Wistar Rats
Creators
- 1. Necmettin Erbakan Univ, Fac Sci, Dept Biotechnol, Konya, Turkiye
- 2. Siirt Univ, Fac Educ, Dept Elementary Educ, Siirt, Turkiye
- 3. Eskisehir Osmangazi Univ, Fac Sci, Dept Biol, Eskisehir, Turkiye
- 4. Ataturk Univ, Dept Dent Serv, Erzurum, Turkiye
- 5. Igdir Univ, Fac Sci, Dept Biochem, Igdir, Turkiye
- 6. Eskisehir Osmangazi Univ, Fac Med, Dept Med Serv & Tech, Eskisehir, Turkiye
Description
The purpose of this study is to measure the effects of acrylamide (AA) on bone marrow and blood and the protective efficacy of boric acid (B) in rats. The animals were divided into five groups: control, B, low-dose B + AA, and high-dose B + AA. After the 15 th day of the experiment, their blood and bone marrow were harvested to be kept for hematological analyses. While white blood cells (WBC) increased following the administration of AA, bodyweight, red blood cells, platelets, hemoglobin, hematocrit, and bone marrow nucleated cell counts significantly decreased in number. Conversely, bodyweight and all these hematological parameters significantly increased apart from WBC in the B + AA groups AA when compared to the control. However, high-dose B was more effective than low-dose B in preventing AA-induced bone marrow and hematological damage. The present study suggests that B treatment could help protect bone marrow and hematological parameters against AA-induced toxicity.
Files
bib-c5b47d40-0f29-4c05-8d35-6e5d1eaadcf0.txt
Files
(251 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:844a9b2e125410c2f88faf45b3b71772
|
251 Bytes | Preview Download |